The hidden dangers of obesity: What you need to know!
Obesity is a complex health issue that has evolved into a global epidemic, affecting millions of individuals across various age groups. Characterised by excessive body ... Read More
Hypertension: Understanding the causes, symptoms, and effective management
Hypertension, commonly known as high blood pressure, is a chronic condition where the force of blood against the artery walls is persistently elevated. While often ... Read More
Urine test breakthrough: A non-invasive solution to diagnosing heart disease
A simple urine test, capable of detecting protein biomarkers, is being hailed as a breakthrough in diagnosing heart disease with 80% accuracy. This innovative diagnostic ... Read More
Hypertension: Understanding the symptoms, causes, and treatment of high blood pressure
Hypertension, or high blood pressure, is a pervasive medical condition that affects millions worldwide. Often referred to as the "silent killer," it frequently progresses without ... Read More
FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction in adults with obesity
The U.S. Food and Drug Administration (FDA) has recently granted an additional indication for Novo Nordisk's Wegovy, a milestone in medical advancements aimed at combating ... Read More
FDA approves Cardio Flow Design’s iTFlow for enhanced cardiovascular diagnosis
The US Food and Drug Administration (FDA) has granted approval for iTFlow, a software solution developed by Cardio Flow Design Inc. (Japan), that improves the ... Read More
CATALYST clinical trial : FDA approves Abbott’s trial of Amplatzer Amulet device in AF
Abbott has been granted approval from the US Food and Drug Administration (FDA) for the CATALYST clinical trial to assess its Amplatzer Amulet Left Atrial ... Read More
Amarin bags Vascepa FDA approval for reducing cardiovascular risk
Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion ... Read More
An egg a day might reduce risk of heart disease: Study
New Delhi, Jan 28 (ANI): A new study conducted in China finds that eating an egg a day may lower risk of cardiovascular disease. The ... Read More
FDA approves Amgen’s Repatha for heart attack and stroke prevention
In a significant advancement for cardiovascular disease management, Amgen's Repatha (evolocumab) has received approval from the U.S. Food and Drug Administration (FDA) to prevent heart ... Read More